In the latest session, Cardiff Oncology Inc (NASDAQ: CRDF) closed at $4.48 up 10.89% from its previous closing price of $4.04. In other words, the price has increased by $+0.4400 from its previous closing price. On the day, 1465981 shares were traded. CRDF stock price reached its highest trading level at $4.5900 during the session, while it also had its lowest trading level at $4.0000.
Ratios:
For a deeper understanding of Cardiff Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 19 ’23 when PACE GARY W bought 30,000 shares for $1.37 per share. The transaction valued at 41,100 led to the insider holds 697,761 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDF now has a Market Capitalization of 200.15M and an Enterprise Value of 127.48M. For the stock, the TTM Price-to-Sale (P/S) ratio is 408.50 while its Price-to-Book (P/B) ratio in mrq is 2.87. Its current Enterprise Value per Revenue stands at 261.23 whereas that against EBITDA is -2.83.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $4.36, while it has fallen to a 52-week low of $0.94. The 50-Day Moving Average of the stock is 1.9874, while the 200-Day Moving Average is calculated to be 1.5987.
Shares Statistics:
For the past three months, CRDF has traded an average of 1.32M shares per day and 7.32M over the past ten days. A total of 44.68M shares are outstanding, with a floating share count of 41.07M. Insiders hold about 8.07% of the company’s shares, while institutions hold 12.13% stake in the company. Shares short for CRDF as of Feb 29, 2024 were 1.15M with a Short Ratio of 0.88, compared to 1.29M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.59% and a Short% of Float of 2.66%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.25 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.27, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.24 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.8 and -$1.06 for the fiscal current year, implying an average EPS of -$0.97. EPS for the following year is -$1.05, with 3 analysts recommending between -$0.8 and -$1.19.
